IL6 and depressive symptom measurement: Multiple Mendelian randomization analyses have demonstrated the connection between IL-6 signaling pathway and various disorders, including Depression,[16] rheumatoid arthritis,[17] systemic lupus erythematosus,[18] Breast Cancer,[19] etc. However, to the best of our knowledge, there is currently no systematic analysis and summary in this area.